India’s Bharat Biotech said on Tuesday its oral cholera vaccine cleared a latestage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding outbreak of the disease and treatment shortages.
Discover more from The Doon Mozaic
Subscribe to get the latest posts sent to your email.